Resource utilization in patients with large B-cell lymphoma receiving tisagenlecleucel and axicabtagene ciloleucel

被引：1
|
作者：
Mian, Agrima [1 ]
Wei, Wei [2 ]
Hamilton, Betty K. [3 ]
Winter, Allison M. [3 ]
Khouri, Jack [3 ]
Pohlman, Brad [3 ]
Gerds, Aaron T. [3 ]
Jagadeesh, Deepa [3 ]
Anwer, Faiz [3 ]
Kalaycio, Matt [3 ]
Dean, Robert M. [3 ]
Sobecks, Ronald [3 ]
Caimi, Paolo F. [3 ]
Hill, Brian T. [3 ]
Majhail, Navneet S. [4 ]
机构：
[1] Cleveland Clin, Dept Internal Med, Cleveland, OH USA
[2] Cleveland Clin, Dept Quantitat Hlth Sci, Cleveland, OH USA
[3] Cleveland Clin, Dept Hematol & Med Oncol, Blood & Marrow Transplant Program, Cleveland, OH USA
[4] Sarah Cannon, Nashville, TN 37203 USA
来源：
BONE MARROW TRANSPLANTATION | 2023年 / 58卷 / 05期
关键词：
TRANSPLANTATION; OUTCOMES; THERAPY;
D O I：
10.1038/s41409-023-01934-4
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：590 / 593
页数：4
相关论文
共 50 条
  • [1] Resource utilization in patients with large B-cell lymphoma receiving tisagenlecleucel and axicabtagene ciloleucel
    Agrima Mian
    Wei Wei
    Betty K. Hamilton
    Allison M. Winter
    Jack Khouri
    Brad Pohlman
    Aaron T. Gerds
    Deepa Jagadeesh
    Faiz Anwer
    Matt Kalaycio
    Robert M. Dean
    Ronald Sobecks
    Paolo F. Caimi
    Brian T. Hill
    Navneet S. Majhail
    Bone Marrow Transplantation, 2023, 58 : 590 - 593
  • [2] Resource Utilization and Factors Prolonging Hospitalization for Patients with Relapsed and Refractory Large B-Cell Lymphoma Receiving Tisagenlecleucel Versus Axicabtagene Ciloleucel
    Mian, Agrima
    Wei, Wei
    Hill, Brian T.
    Hamilton, Betty K.
    Winter, Allison M.
    Khouri, Jack
    Pohlman, Brad
    Jagadeesh, Deepa
    Garcia, Alex V. Mejia
    Anwer, Faiz
    Gerds, Aaron T.
    Kalaycio, Matt
    Dean, Robert M.
    Sobecks, Ronald
    Majhail, Navneet S.
    BLOOD, 2020, 136
  • [3] Axicabtagene Ciloleucel in Large B-Cell Lymphoma
    Zhao, Wei-Li
    Wu, De-pei
    Hu, Yu
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 389 (12): : 1152 - 1153
  • [4] Prophylactic corticosteroid use in patients receiving axicabtagene ciloleucel for large B-cell lymphoma
    Oluwole, Olalekan O.
    Bouabdallah, Krimo
    Munoz, Javier
    De Guibert, Sophie
    Vose, Julie M.
    Bartlett, Nancy L.
    Lin, Yi
    Deol, Abhinav
    McSweeney, Peter A.
    Goy, Andre H.
    Kersten, Marie Jose
    Jacobson, Caron A.
    Farooq, Umar
    Minnema, Monique C.
    Thieblemont, Catherine
    Timmerman, John M.
    Stiff, Patrick
    Avivi, Irit
    Tzachanis, Dimitrios
    Kim, Jenny J.
    Bashir, Zahid
    McLeroy, Jeff
    Zheng, Yan
    Rossi, John M.
    Johnson, Lisa
    Goyal, Lovely
    van Meerten, Tom
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 194 (04) : 690 - 700
  • [5] Axicabtagene ciloleucel compared to tisagenlecleucel for the treatment of aggressive B-cell lymphoma
    Kwon, Mi
    Iacoboni, Gloria
    Reguera, Juan Luis
    Corral, Lucia Lopez
    Morales, Rafael Hernani
    Ortiz-Maldonado, Valentin
    Guerreiro, Manuel
    Caballero, Ana Carolina
    Dominguez, Maria Luisa Guerra
    Pina, Jose Maria Sanchez
    Mussetti, Alberto
    Sancho, Juan Manuel
    Bastos-Oreiro, Mariana
    Catala, Eva
    Delgado, Javier
    Henriquez, Hugo Luzardo
    Sanz, Jaime
    Calbacho, Maria
    Bailen, Rebeca
    Carpio, Cecilia
    Ribera, Jose Maria
    Sureda, Anna
    Briones, Javier
    Hernandez-Boluda, Juan Carlos
    Cebrian, Nuria Martinez
    Martin, Jose Luis Diez
    Martin, Alejandro
    Barba, Pere
    HAEMATOLOGICA, 2023, 108 (01) : 110 - 121
  • [6] No Impact of Prophylactic Corticosteroid Use in Patients Receiving Axicabtagene Ciloleucel for Large B-Cell Lymphoma
    Melody, Megan
    Franco, Stephanie
    Odetola, Oluwatobi
    Lin, Adam
    Moreira, Jonathan
    Carson, Kenneth
    Ma, Shuo
    Winter, Jane N.
    Gordon, Leo
    Karmali, Reem
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S611 - S612
  • [7] Survival with Axicabtagene Ciloleucel in Large B-Cell Lymphoma
    Westin, Jason R.
    Oluwole, Olalekan O.
    Kersten, Marie Jose
    Miklos, David B.
    Perales, Miguel-Angel
    Ghobadi, Armin
    Rapoport, Aaron P.
    Sureda, Anna
    Jacobson, Caron A.
    Farooq, Umar
    van Meerten, Tom
    Ulrickson, Matthew
    Elsawy, Mahmoud
    Leslie, Lori A.
    Chaganti, Sridhar
    Dickinson, Michael
    Dorritie, Kathleen
    Reagan, Patrick M.
    McGuirk, Joseph
    Song, Kevin W.
    Riedell, Peter A.
    Minnema, Monique C.
    Yang, Yin
    Vardhanabhuti, Saran
    Filosto, Simone
    Cheng, Paul
    Shahani, Shilpa A.
    Schupp, Marco
    To, Christina
    Locke, Frederick L.
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 389 (02): : 148 - 157
  • [8] Resource Utilization and Factors Prolonging Hospitalization for Patients with Refractory and Relapsed B-Cell Lymphoma Receiving Axicabtagene Ciloleucel (Axi-cel)
    Mian, Agrima
    Wei, Wei
    Hill, Brian T.
    Hamilton, Betty K.
    Pohlman, Brad
    Jagadeesh, Deepa
    Anwer, Faiz
    Kalaycio, Matt E.
    Dean, Robert M.
    Sobecks, Ronald M.
    Majhail, Navneet S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (03) : S44 - S45
  • [9] Earlier corticosteroid use for adverse event management in patients receiving axicabtagene ciloleucel for large B-cell lymphoma
    Topp, Max S.
    van Meerten, Tom
    Houot, Roch
    Minnema, Monique C.
    Bouabdallah, Krimo
    Lugtenburg, Pieternella J.
    Thieblemont, Catherine
    Wermke, Martin
    Song, Kevin W.
    Avivi, Irit
    Kuruvilla, John
    Duehrsen, Ulrich
    Zheng, Yan
    Vardhanabhuti, Saran
    Dong, Jinghui
    Bot, Adrian
    Rossi, John M.
    Plaks, Vicki
    Sherman, Marika
    Kim, Jenny J.
    Kerber, Anne
    Kersten, Marie Jose
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 195 (03) : 388 - 398
  • [10] Real-world healthcare resource utilization and costs associated with tisagenlecleucel and axicabtagene ciloleucel among patients with diffuse large B-cell lymphoma: an analysis of hospital data in the United States
    Maziarz, Richard T.
    Yang, Hongbo
    Liu, Qing
    Wang, Travis
    Zhao, Jing
    Lim, Stephen
    Lee, Soyon
    Dalal, Anand
    Bollu, Vamsi
    LEUKEMIA & LYMPHOMA, 2022, 63 (09) : 2052 - 2062
12345